title: Venous thrombosis: preventing clots in patients at risk.
authors.affiliation: Auburn University, Harrison School of Pharmacy, Auburn, AL, USA. mccrahl@auburn.edu
authors.forename: Haley M
authors.initials: HM
authors.lastname: Phillippe
authors.forename: Amanda Y
authors.initials: AY
authors.lastname: Sparkman
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects; D016736:Antiphospholipid Syndrome / Q000150:complications; D001780:Blood Coagulation Tests; D005165:Factor V / Q000235:genetics; D005260:Female; D005820:Genetic Testing; D006493:Heparin / Q000009:adverse effects; D020249:Hormone Replacement Therapy / Q000009:adverse effects; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications / Q000175:diagnosis; D009154:Mutation; D009369:Neoplasms / Q000150:complications; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic; D011516:Prothrombin / Q000235:genetics; D013921:Thrombocytopenia / Q000139:chemically induced; D019851:Thrombophilia / Q000150:complications / Q000175:diagnosis; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; C095381:factor V Leiden; D005165:Factor V; D011516:Prothrombin; D006493:Heparin